SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001140361-11-010946
Filing Date
2011-02-18
Accepted
2011-02-18 19:18:43
Documents
1
Period of Report
2011-02-16
Filing Date Changed
2011-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 10131
  Complete submission text file 0001140361-11-010946.txt   11893
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 301 TRESSER BOULEVARD SUITE 1320 STAMFORD CT 06901
Business Address 301 TRESSER BOULEVARD SUITE 1320 STAMFORD CT 06901 203-653-2500
Xmark Opportunity Partners, LLC (Reporting) CIK: 0001347039 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-50481 | Film No.: 11626072